Alexandra Schurer

725 total citations
11 papers, 319 citations indexed

About

Alexandra Schurer is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Alexandra Schurer has authored 11 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Hematology and 1 paper in Surgery. Recurrent topics in Alexandra Schurer's work include Protein Degradation and Inhibitors (4 papers), RNA modifications and cancer (4 papers) and Acute Myeloid Leukemia Research (3 papers). Alexandra Schurer is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), RNA modifications and cancer (4 papers) and Acute Myeloid Leukemia Research (3 papers). Alexandra Schurer collaborates with scholars based in United States, Canada and Germany. Alexandra Schurer's co-authors include Michael G. Kharas, Yuanming Cheng, Saroj Gourkanti, Ly Vu, Sun‐Mi Park, Diu Nguyen, Brian F. Pickering, Dan A. Landau, Samie R. Jaffrey and Hanzhi Luo and has published in prestigious journals such as Nature Communications, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Alexandra Schurer

11 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Schurer United States 6 250 106 64 43 41 11 319
Kazumasa Sekihara Japan 9 129 0.5× 35 0.3× 52 0.8× 32 0.7× 26 0.6× 13 209
Ruonan Shao China 9 186 0.7× 97 0.9× 53 0.8× 89 2.1× 51 1.2× 26 296
Bianca Busch Germany 9 387 1.5× 278 2.6× 8 0.1× 26 0.6× 29 0.7× 9 439
Roberto Ciaccio Italy 3 184 0.7× 48 0.5× 15 0.2× 53 1.2× 16 0.4× 4 229
Kenneth Finne Norway 10 159 0.6× 40 0.4× 20 0.3× 32 0.7× 36 0.9× 15 289
Bonnie LaCroix United States 9 200 0.8× 154 1.5× 10 0.2× 22 0.5× 22 0.5× 12 270
Bin Meng China 8 174 0.7× 58 0.5× 16 0.3× 38 0.9× 24 0.6× 18 224
Yuanming He China 9 246 1.0× 41 0.4× 39 0.6× 89 2.1× 43 1.0× 16 290

Countries citing papers authored by Alexandra Schurer

Since Specialization
Citations

This map shows the geographic impact of Alexandra Schurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Schurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Schurer more than expected).

Fields of papers citing papers by Alexandra Schurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Schurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Schurer. The network helps show where Alexandra Schurer may publish in the future.

Co-authorship network of co-authors of Alexandra Schurer

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Schurer. A scholar is included among the top collaborators of Alexandra Schurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Schurer. Alexandra Schurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schurer, Alexandra, et al.. (2024). Targeting chromatin modifying complexes in acute myeloid leukemia. Stem Cells Translational Medicine. 14(2). 4 indexed citations
2.
Viragova, Sara, Luis Aparicio, Junfei Zhao, et al.. (2023). Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma. JNCI Journal of the National Cancer Institute. 115(7). 838–852. 6 indexed citations
3.
Park, Sun‐Mi, David K. Miyamoto, Jun Hyun Kim, et al.. (2023). Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. Cancer Cell. 41(4). 726–739.e11. 23 indexed citations
4.
Okabe, Rachel, Alexandra Schurer, Meng Tong, et al.. (2022). Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical Cancer Research. 29(5). 943–956. 1 indexed citations
5.
Park, Sun Mi, David K. Miyamoto, Jun Hyun Kim, et al.. (2022). Dual IKZF2 and CK1α Degrader Targets Acute Myeloid Leukemia Cells. Blood. 140(Supplement 1). 675–676. 3 indexed citations
6.
Jeong, Sangmoo, Angela Maria Savino, Rachel Chirayil, et al.. (2020). High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells. Cell Metabolism. 33(1). 145–159.e6. 51 indexed citations
7.
Nguyen, Diu, Zhaoqi Liu, Justin C. Wheat, et al.. (2020). Transcriptional Control of HP1a By the RNA Binding Proteins Rbmx/L1 Maintain Chromatin State in Myeloid Leukemia. Blood. 136(Supplement 1). 15–15. 2 indexed citations
8.
Nguyen, Diu, Yuheng Lu, Xuejing Yang, et al.. (2020). HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells. Nature Communications. 11(1). 2026–2026. 36 indexed citations
9.
Cheng, Yuanming, Hanzhi Luo, Franco Izzo, et al.. (2019). m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment. Cell Reports. 28(7). 1703–1716.e6. 126 indexed citations
10.
Park, Sun‐Mi, Hyunwoo Cho, Angela M. Thornton, et al.. (2018). IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation. Cell stem cell. 24(1). 153–165.e7. 65 indexed citations
11.
Nguyen, Diu, Ly Vu, Alexendar R. Perez, et al.. (2018). RNA Binding Protein Rbmx Is Required in Acute Myeloid Leukemia By Regulating the Transcriptional Activity of the Heterochromatin Protein HP1α. Blood. 132(Supplement 1). 883–883. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026